SUNPHARMA — Sun Pharmaceutical Industries Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual balance sheet for Sun Pharmaceutical Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2022 March 31st	2023 March 31st	R2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	127,169	151,477	191,135	250,330	339,402
Net Total Accounts Receivable
Net Total Receivables	121,851	129,598	132,557	149,608	155,624
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	348,646	398,619	434,331	525,941	638,603
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	111,689	113,537	113,001	112,703	124,948
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	698,078	807,436	854,997	921,006	1,087,852
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	172,085	199,064	169,838	181,942	226,220
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	217,966	247,482	218,329	198,826	252,151
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	480,112	559,954	636,668	722,180	835,701
Total Liabilities & Shareholders' Equity	698,078	807,436	854,997	921,006	1,087,852
Total Common Shares Outstanding